Neurovascular Catheters Market (By Type: Microcatheters, Balloon Catheters, Access Catheters, Embolization Catheters, Others; By Application: Embolic Stroke, Brain Aneurysms, Arteriovenous Malformations, Others; By End Use: Hospital, Clinics, Ambulatory Surgical Centers, Diagnostic Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032


The global neurovascular catheters market size was reached at USD 4.03 billion in 2022 and it is expected to hit around USD 17.1 billion by 2032, growing at a CAGR of 15.6% during the forecast period 2023 to 2032.

Neurovascular Catheters Market Size 2023 To 2032

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Key Takeaways:

  • North America dominated the market with the largest market of 35% in 2022.
  • Asia Pacific is expected to witness significant market growth during the forecast period.
  • By Type, the embolization catheters segment dominated the market with the highest market share of 35% in 2022.
  • By Type, the microcatheters segment is expected to grow at a significant rate during the forecast period.
  • By Application, the brain aneurysms segment dominated the global market with the largest market share of 34% in 2022.
  • By End-use, the hospital segment contributed more than 56% of revenue share in 2022.
  • By End-use, the ambulatory surgical centers segment is expected to grow at a significant rate during the forecast period.

Neurovascular Catheters Market Overview:

The neurovascular catheter is a medical device that is useful in the treatment of patients with neurological conditions. It is a tube-shaped device that is used during brain surgeries of patients. Catheters are used in medical devices to be inserted in the body for the treatment of a particular disease, especially during surgeries. These catheters play an important role in various medical procedures, such as monitoring intracranial pressure, administering medications and injecting contrast agents. The most common application of neurovascular catheters is to manage the condition of hydrocephalus, which helps in regulating the blood flow of cerebrospinal fluid. They are also employed during the treatment of head injuries or during neurosurgery.

Growth Factors:

Changing lifestyle in recent times tends to the higher prevalence of neurological condition such as brain aneurysms and stroke contributing to the growth of the neurovascular catheters market. In recent times minimal surgeries have increased and gained popularity due to minimizing the trauma and risk which is associated with surgical procedures. Thus, this element is accelerating the growth of the market.

The rising rate of strokes and blockages in blood vessels in the brain act as a growth factor for the market. Increasing cases of strokes or accidents result in blockage in blood vessels or injured blood vessels which results in several problems in the brain. Minimal surgeries are responsible for curing or treating this kind of brain wound by surgeries. For removing the blockage or curing the injured blood vessel in the brain there are endovascular techniques that are widely preferred.  For the treatment and minimal surgeries, the neurovascular catheters are combined with other medical devices for the surgical process for the cure of stroke, aneurysm, and other injuries and blood vessel conditions.

Neurovascular Catheters Market Scope

Report Coverage Details
Market Size in 2023 USD 5.47 Billion
Market Size by 2032 USD 10.88 Billion
Growth Rate from 2023 to 2032 CAGR of 7.93%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2022
Forecast Period 2023 To 2032
Segments Covered By Type, By Application, and By End Use
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa


Neurovascular Catheters Market Dynamics:

Driver:

Implementation of advanced neurovascular access (ANA)

An innovative stroke thrombectomy tool called Advanced Neurovascular Access has a self-expanding funnel component. This device is designed to restrict local blood flow while extending to the same width as the lodging artery in order to decrease the negative effects brought on by clot breakup. When the ANA device is deployed, it allows distal aspiration when combined with a stent retriever (SR) to transfer the clot into the tube, where it is caught and kept safe for extraction. With the adoption of advanced medical devices and tools, the implementation of ANA is observed to grow in the upcoming years while promoting the market’s growth.

Restraint:

Lack of professionals

The absence of a skilled workforce poses a significant restraint for the global neurovascular catheters market. The intricate nature of these medical devices demands specialized expertise for their successful use and maintenance. A shortage of trained professionals capable of accurately inserting and managing neurovascular catheters may lead to complications, procedural errors and reduced patient outcomes. Moreover, the need for continuous monitoring and precise adjustments necessitates proficient healthcare practitioners to ensure optimal device performance. Thus, the factor acts as a major restraint for the market.

Opportunity:

AI and ML in neurovascular surgeries

Endovascular neurosurgery holds the potential to revolutionize neurovascular care with the application of robotics and artificial intelligence (AI).  integration of artificial intelligence holds the capacity to interpret data and utilize the same for modeling human behavior. Machine learning models are also being heavily employed in the healthcare sector, which helps in analyzing patterns to detect associations in a dataset. Integration of artificial intelligence and machine learning can ease the decision-making during surgeries by availing the capabilities of neurovascular catheters in a more effective manner. All these capacities of AI and ML are observed to improve the overall effectiveness of neurovascular catheters for patients. Thus, the integration of AI and ML is expected to open a set of lucrative opportunities for the market.

Type Insights:

The embolization catheter segment dominated the market in 2022. The segment's dominance is attributed to the growing use of embolization catheters in brain surgeries. The specific medication or synthetic material placed which is called an embolic agent by the embolization catheters into the blood vessel to block the blood flow to an area of the body. The healthcare professional delivers the embolic agents through long and thin tubes. The catheter is inserted by making a puncture in the skin and it follows the blood vessels and the treatment area. There are several types of embolic agents that are used in the procedure like balloons, gelatin foam, liquid glue, liquid sclerosing agents, metallic coils, and particular agents.

The microcatheters segment is expected to grow at a significant rate during the forecast period. Microcatheters are medical devices with diameter and are used in minimally invasive procedures. The Microcatheters are used for exchanges, guidewire support, cross lesions, accessing distal anatomy, delivering therapeutic embolic, injecting contrast media, and other complex endovascular procedures.

Application Insights:

The brain aneurysms segment dominated the market in 2022. A brain aneurysm is a type of brain condition or disease in which a bulge and balloon in blood vessel is formed. It is also known as a cerebral aneurysm or intracranial aneurysm. It may cause some serious issues and health problems like Subarachnoid hemorrhage, Hemorrhagic stroke, Vasospasm, Hydrocephalus, Seizures, and Coma a neurovascular catheter is used in surgeries for blockage of extra blood flow to the weak wall of the blood vessel and helps in the treatment and surgery of the disease. Multiple studies show that catheter is the most successful form of treatment for aneurysms.

End-Use Insights:

The hospital segment dominated the market in 2022, the segment is expected to sustain dominance throughout the forecast period. Rising patient number in neurology section for the treatment of brain aneurysm, Traumatic brain injury (TBI), ischemic & hemorrhagic stroke, and Arteriovenous Malformation (AVM) in specialty hospitals is considered to be the major factor for the segment’s dominance. Technological advancements in surgical processes along with the potential of adopting such methods rapidly has been supporting the segment’s growth. Moreover, the adoption of robotics intervention by the hospitals/specialty hospitals will promote the segment’s growth.

On the other hand, the ambulatory surgical centers segment is expected to be the most attractive segment of the market. Ambulatory surgical centers offer convenience for patients along with multiple advanced procedures for surgeries. Most ambulatory surgical centers allow the coverage of surgeries through health insurance, this opens door for patients to choose these focused centers for treatments.

Regional Insights:

North America dominated the market with the largest market size in 2022, the region is expected to continue the trend during the forecast period. The growth of the market in the region is attributed to the presence of major players that are based mainly in the Unites States. With this factor, the Unites States is expected to be the largest contributor to the market, followed by Canada. The rising number of brain surgeries in the region with the availability of advanced healthcare infrastructure plays a vital role in the market’s development in the region. The market in North America is expected to continue its growth trend with the ongoing advancements in the catheter design to offer more effective results. Moreover, the potential of investing in research and development activities with substantial support from the government supports the market’s development.

Neurovascular Catheters Market Share, By Region, 2022 (%)

Asia Pacific is expected to witness the fastest rate of growth during the forecast period. The rising number of neurological disorders and increasing prevalence of brain illness in the population are driving the growth of the market across the region. Moreover, rising technological advancements in the surgeries with improving healthcare infrastructure is considered to be a potential growth factor in the market’s development in Asia Pacific. In addition, the rising awareness for advanced medical treatments in the region along with the presence of aging population in the region promotes the growth of the market in Asia Pacific.

Countries such as Japan, South Korea, India and China have now emerged to be leading players of the market in Asia Pacific. Moreover, collaborations and business activities between local and international players for research, development and launch of medical devices also supplement the market’s development in Asia Pacific.

Recent Developments:

  • In July 2023, a global leader in cardiac arrhythmia treatment “Biosense Webster, Inc.” and some part of Johnson MedTech announced the launch of the OPTRELL, mapping Catheter with TRUEref™ Technology powered by the CARTO® 3 System.
  • In August 2023, Ra Medical System Inc. completed its association with Catheters Precision Inc., a company which is working on the cardiac electrophysiology market.
  • In August 2023, ReCor Medical announced the win FDA panel nod for its renal denervation system. The FDA approved and is in approval of the efficiency and safety of its Paradise ultrasound renal denervation for the treatment of hypertension.
  • In August 2023, fast-track designation to its endovascular aneurysm stabilization treatment (EAST) system was approved by the FDA which was announced by Nectero Medical. Stabilizer mixture containing pentagalloyl glucose (PGG) and dual-balloon delivery catheter which is included in Nectero EAST.

Neurovascular Catheters Market Companies

  • Medtronic
  • Stryker
  • Terumo Corporation
  • Integer Holdings Corporation
  • Penumbra, Inc.
  • Johnson & Johnson Services, Inc.
  • Integra LifeSciences Corporation
  • Acandis GmbH
  • Spiegelberg GmbH & Co. KG

Segments Covered in the Report:

By Type

  • Microcatheters
  • Balloon Catheters
  • Access Catheters
  • Embolization Catheters
  • Others

By Application

  • Embolic Stroke
  • Brain Aneurysms
  • Arteriovenous Malformations
  • Others

By End Use

  • Hospital
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

What is the neurovascular catheters market size?
The global neurovascular catheters market size is expected to be worth around USD 10.88 billion by 2032 from valued at USD 5.07 billion in 2022.
What will be the CAGR of global neurovascular catheters market?
The global neurovascular catheters market will register growth rate of 7.93% between 2023 and 2032.
Who are the prominent players operating in the neurovascular catheters market?
The major players operating in the neurovascular catheters market are Medtronic, Stryker, Terumo Corporation, Integer Holdings Corporation, Penumbra, Inc., Johnson & Johnson Services, Inc., Integra LifeSciences Corporation Acandis GmbH, Spiegelberg GmbH & Co. KG, and Others.
Which are the driving factors of the neurovascular catheters market?
The driving factors of the neurovascular catheters market are the Implementation of advanced neurovascular access (ANA) and the rising rate of strokes and blockages in blood vessels in the brain.
Which region will lead the global neurovascular catheters market?
North America region will lead the global neurovascular catheters market during the forecast period 2023 to 2032.

PROCEED TO BUY :

   USD 5400
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample